St. Paul-based pharmaceutical company CNS Therapeutics named Andy LaFrence as its chief financial officer.
LaFrence was previously an audit partner at accounting firm KPMG.
"Andy's tremendous insight from the pharmaceutical, medical technology and financial markets is instrumental to our rapidly growing business," said CEO John Foster.
CNS Therapeutics received FDA approval last year for its generic version of a drug to treat severe spasticity.
Scott Bronson, the company's co-founder, is administrative and compliance officer. Bronson was previously CFO.
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More From Star Tribune
More From Star Tribune
Sports
Canterbury Park: Entries, picks, results and more
Picks from Star Tribune handicapper Jay Lietzau and everything you need for a day at the races.
Local
What to know about the latest COVID variants, Minnesota testing, vaccines
Expert advice on masking, testing, vaccines and boosters is evolving along with coronavirus variants. Here's the latest from Minnesota and the CDC.
Sign up for Star Tribune newsletters
Subscribe to Star Tribune newsletters, including Essential Minnesota, breaking news and Hot Dish.
Drone footage shows Ukrainian village battered to ruins as residents flee Russian advance
The Ukrainian village of Ocheretyne has been battered by fighting, drone footage shows. The village has been a target for Russian forces in Donetsk.